Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1-Reference-Cited by-同舟云学术

Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1

Published:2013-11-20 Issue:4 Volume:16 Page:357-365
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Pathak V.¹,Vasu S.¹,Flatt P. R.¹,Irwin N.¹

Affiliation:

1. SAAD Centre for Pharmacy Diabetes; University of Ulster; Coleraine UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12227/fullpdf

Reference39 articles.

1. Pharmacology, physiology, and mechanisms of incretin hormone action;Campbell;Cell Metab,2013

2. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene;Scrocchi;Nat Med,1996

3. Chronic desensitization of the glucose-dependent insulinotropic polypeptide receptor in diabetic rats;Tseng;Am J Physiol,1996

4. Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans;Schirra;J Clin Invest,1998

5. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice;Miyawaki;Proc Natl Acad Sci U S A,1999

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing a CT-based radiomics nomogram for predicting post-acute pancreatitis diabetes mellitus incidence;The British Journal of Radiology;2023-10-24

2. Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options;Molecules;2023-03-30

3. Polypharmacology in Clinical Applications: Metabolic Disease Polypharmacology;Polypharmacology;2022

4. Type 2 Diabetes Mellitus: A Review of Multi-Target Drugs;Molecules;2020-04-23

5. A GIP/xenin hybrid in combination with exendin-4 improves metabolic status in db/db diabetic mice and promotes enduring antidiabetic benefits in high fat fed mice;Biochemical Pharmacology;2020-01